
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options with no options contract fees
- Get up to $1,000 in stock when you open and fund a new account within 30 days
- Access to a financial planner
Israeli cannabis producer Intercure has applied to have its stock listed on the Nasdaq. The stock is currently listed on the Toronto Stock Exchange under the ticker symbol "INCR:U" and on the Tel Aviv Stock Exchange under the ticker symbol "INCR." If accepted, the stock will trade on the Nasdaq under the same symbol.
We'll update this page as new information becomes available.
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Latest market close | $1.55 |
---|---|
52-week range | $1.17 - $3.39 |
50-day moving average | $1.46 |
200-day moving average | $1.65 |
Wall St. target price | $33.56 |
PE ratio | N/A |
Dividend yield | N/A |
Earnings per share (TTM) | $-0.42 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $1.5478 from 2025-05-22
1 week (2025-05-16) | 2.17% |
---|---|
1 month (2025-04-25) | 4.58% |
3 months (2025-02-25) | -5.04% |
6 months (2024-11-25) | 9.00% |
1 year (2024-05-24) | -51.17% |
---|---|
2 years (2023-05-24) | -27.33% |
3 years (2022-05-24) | 6.79 |
5 years (2020-05-22) | 5.784 |
Revenue TTM | $238.8 million |
---|---|
Gross profit TTM | $42.1 million |
Return on assets TTM | -7.09% |
Return on equity TTM | -17.03% |
Profit margin | -28.39% |
Book value | $8.42 |
Market Capitalization | $82.6 million |
TTM: trailing 12 months
We're not expecting Intercure to pay a dividend over the next 12 months.
You may also wish to consider:
Intercure's shares were split on a 946:4209 basis on 7 April 2021 . So if you had owned 4209 shares the day before before the split, the next day you'd have owned 946 shares. This wouldn't directly have changed the overall worth of your Intercure shares – just the quantity. However, indirectly, the new 344.9% higher share price could have impacted the market appetite for Intercure shares which in turn could have impacted Intercure's share price.
Over the last 12 months, Intercure's shares have ranged in value from as little as $1.17 up to $3.39. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Intercure's is 0.507. This would suggest that Intercure's shares are less volatile than average (for this exchange).
To put Intercure's beta into context you can compare it against those of similar companies.
InterCure Ltd. , together with its subsidiaries, engages in the research, marketing, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel. .
Learn how and where to buy Fannie Mae (FNMA) stock, view trends and see what may be ahead for share holders.
See how and where to buy Freddie Mac (FMCC) stock, view past price performance and learn what’s ahead for shareholders.
Direct indexing lets you replicate the performance of a specific index with potentially more tax efficiency. Learn how to get started here.
A deep dive into the highlights and limitations of Frec.
Explore the best bonuses for opening a new brokerage account.
It can help reduce taxes owed, but it’s not for beginners.
A beginner-friendly investing platform with fractional shares and no commissions on stocks and ETFs.
SoFi Invest is a no-fee commissions platform with both active and automated investment accounts.
The ins and outs of bundling stocks with this accessible investing option.
A deep dive into the highlights and limitations of Robinhood.